Table 1.
Parameter | Bilateral PA patients n = 1386 | Unilateral PA patients n = 200 | P |
---|---|---|---|
Age, years | 51.8 ± 10.9 | 53.7 ± 11.3 | 0.022* |
Sex, male, % | 43.4 | 71.5 | <0.001* |
Body mass index, kg/m2 | 25.2 ± 4.1 | 25.3 ± 4.1 | 0.784 |
History of Smoking, % | 32.1 | 38.2 | 0.094 |
History of Drinking, % | 52.0 | 61.3 | 0.017* |
Systolic blood pressure, mmHg | 142.1 ± 17.3 | 141.8 ± 18.3 | 0.792 |
Diastolic blood pressure, mmHg | 87.9 ± 13.1 | 87.5 ± 13.0 | 0.676 |
Hypertension duration, years | 3 (1-10) | 10 (4-18) | <0.001* |
Creatinine, mg/dl | 0.73 ± 0.22 | 0.82 ± 0.23 | <0.001* |
EGFR, ml/min/1.73m2 | 79.4 ± 17.2 | 77.0 ± 21.1 | 0.087 |
Low eGFR, % | 11.1 | 16.0 | 0.043* |
Proteinuria, % | 7.4 | 17.0 | <0.001* |
Total cholesterol, mg/dl | 198 ± 33 | 188 ± 33 | <0.001* |
Triglyceride, mg/dl | 132 ± 82 | 123 ± 66 | 0.184 |
LDL, mg/dl | 116 ± 29 | 112 ± 29 | 0.112 |
HDL, mg/dl | 57 ± 17 | 54 ± 15 | 0.024* |
Dyslipidemia, % | 27.9 | 34.1 | 0.089 |
Fasting blood sugar, mg/dl | 106 ± 30 | 108 ± 29 | 0.446 |
HbA1c (NGSP), % | 5.9 ± 1.0 | 5.8 ± 1.0 | 0.575 |
Diabetes mellitus, % | 18.9 | 20.7 | 0.552 |
Serum K+, mEq/l | 3.9 ± 0.4 | 3.5 ± 0.5 | <0.001* |
Hypokalemia, % | 16.9 | 62.0 | <0.001* |
ARR, pg/ml per ng/ml/h | 420 (290-660) | 772 (427-1529) | <0.001* |
PAC, pg/ml | 156 (118-213) | 228 (164-338) | <0.001* |
PRA, ng/ml/h | 0.4 (0.2-0.6) | 0.3 (0.2-0.5) | <0.001* |
Cardiovascular disease, % | 6.2 | 10.0 | 0.045* |
Student’s t test was used to compare parametric variables. The Mann-Whitney U test was used to compare nonparametric variables. Pearson’s χ2 test was used for categorical parameters. Asterisks (*) indicate significant differences (P <0.05). Hypokalemia was considered to be present if K+ was ≤3.5 mEq/L or when a patient was taking a potassium supplement. Low eGFR was defined as eGFR <60 ml/min/1.73m2. ARR, aldosterone-to-renin ratio; EGFR, estimated glomerular filtration rate; HDL, high density lipoprotein; LDL, low density lipoprotein; PA, primary aldosteronism; PAC, plasma aldosterone concentration; and PRA, plasma renin activity.